ACTRN12615000786594进行中（未招募）未知
A Double-Blind Randomised Crossover Trial to Determine the Clinical and Physiological Impact of Temporarily Interrupting Sacral Neuromodulation in Patients with Faecal Incontinence
Professor Marc A Gladman0 个研究点目标入组 20 人开始时间: 2015年7月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Age >18 years
- •2. Predominant symptom: faecal Incontinence
- •3. Have been implanted with a permanent sacral nerve stimulator for at least 6 months
- •4. Subjective improvement in symptoms of faecal incontinence compared to baseline (i.e prior to the implantation of the stimulation device)
排除标准
- •1. Non-English speaking
- •2. Cognitive impairment
- •3. Non-ambulatory
- •4. Pregnancy
- •5. Neurological disorders e.g. Spina Bifida or Multiple Sclerosis
研究者
相似试验
已完成
不适用
A Randomized, double-blind Crossover Trial to Investigate the Effects of Oliceridine and Morphine on Ventilatory Drive and Pain Relief in Healthy Elderly Subjects * a population pharmacokinetic/pharmacodynamic modeling studyNL-OMON50904eids Universitair Medisch Centrum18
招募中
4 期
asal versus Epidural Fentanyl for Patient Controlled Analgesia after Caesarean SectioPostoperative pain following caesarean section.Reproductive Health and Childbirth - Normal pregnancyAlternative and Complementary Medicine - Pain managementSurgery - Other surgeryACTRN12605000327684Professor Michael Paech60
进行中（未招募）
1 期
Randomised, Double-Blind, Cross-over Study to Determine the 24-hour FEV1-time Profile of Orally Inhaled BI 1744 CL, delivered with the Respimat® Inhaler, after 3 Weeks of Once Daily (5 mcg [2 actuations of 2,5 mg], 10 mcg [2 actuations of 5 mcg]) or Twice Daily (2 mcg [2 actuations of 1 mcg], 5 mg [2 actuations of 2,5 mcg]) Administration in Patients with Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 9.1Level: LLTClassification code 10010952Term: COPDEUCTR2008-006334-10-NLBoehringer Ingelheim BV48
已完成
4 期
A randomized double blind cross-over trial of the effects of low dose and high dose hydrocortisone replacement therapy on cognition, quality of life, metabolic profile and somatosensation in patients with secondary adrenal insufficiencyadrenal insufficiencysecondary adrenal insufficiency10021112NL-OMON38411niversitair Medisch Centrum Groningen63
已完成
不适用
Cross-over randomised trial of adult hypothyroidism screeningPrimary hypothyroidismNutritional, Metabolic, EndocrineOther hypothyroidismISRCTN00049084Queen Mary University of London (UK)60